End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
14.48 USD | -0.14% | +6.08% | +26.13% |
Apr. 30 | Alvotech to Manufacture Humira Biosimilar for Quallent Pharmaceuticals | MT |
Apr. 30 | Alvotech to Make Humira Biosimilar Adalimumab-ryvk for Quallent | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+26.13% | 4.06B | |
+25.68% | 48.09B | |
+46.90% | 40.62B | |
-3.06% | 40.43B | |
-6.20% | 28.36B | |
+9.39% | 24.89B | |
-19.92% | 19.01B | |
+28.73% | 12.09B | |
+0.56% | 11.88B | |
-1.36% | 11.8B |
- Stock Market
- Equities
- ALVO Stock
- News Alvotech
- Alvotech Signs Agreement to Expand Access to Humira Biosimilar Adalimumab-ryvk in US